Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Australian Prescriber|March 5, 2025
Drug safety in pregnancyDebra Kennedy, Ronald Batagol
Obstetric Medicine|August 12, 2016
Ondansetron and pregnancy: Understanding the dataDebra Kennedy
Prenatal Diagnosis|June 12, 2020
An update on maternal medication-related embryopathiesWillem Gheysen, Debra Kennedy
The New Zealand Medical Journal|May 11, 2004
Frequent attenders at Christchurch Hospital's Emergency Department: a 4-year study of attendance patternsDebra Kennedy, Michael Ardagh
Obstetric Medicine|September 1, 2016
Arthritis in pregnancy: the role and safety of biological agentsPeter Youssef, Debra Kennedy
The Australian & New Zealand Journal of Obstetrics & Gynaecology|May 13, 2009
MotherSafe: review of three years of counselling by an Australian Teratology Information ServiceJoy Marie Lim, Elizabeth Sullivan, Debra Kennedy
The Australian & New Zealand Journal of Obstetrics & Gynaecology|September 14, 2013
Review of calls to an Australian teratogen information service regarding psychotropic medications over a 12-year periodDebra Kennedy, Maya Eamus, Majella Hill, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 27, 2017
Abnormal pregnancy outcome associated with high-dose maternal tranylcypromine therapy: Case report and literature reviewDebra Kennedy, William S Webster, Majella Hill, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|October 5, 2019
Utilisation of a NSW teratology information service by pharmacists and patients referred by a pharmacist from 2000 to 2018Helen Elizabeth Ritchie, Bandana Saini, Michael J Twigg, et al.
Pageof 5